In Vivo Assessment of Geno- and Cytotoxicity of Fluoridated Toothpastes and Mouthrinses on Buccal Epithelial Cells

Sponsor
University of Split, School of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT04801576
Collaborator
(none)
40
1
2
30.9
1.3

Study Details

Study Description

Brief Summary

Buccal cells represent the first barrier to the oral hygiene products' potential toxic effect. The usual concentration of fluoride in toothpastes is 1000/1100 parts per million (ppm F); toothpastes with higher (1500 ppm F) and lower than conventional fluoride levels (around 500 ppm F) are available in many countries. Toothpastes containing higher concentrations of fluoride confer greater protection against caries but at the same time the fluoride is able to induce harmful effects on oral mucosa cells.

The study would include around 40 participants, aged between 20 and 65, divided in two groups. Each group will use fluoride free toothpaste for 28 days, than afterwards group B will get toothpastes (each for 28 days) with no fluoride, 1045 ppm F and 1450 ppm F used together with mouthrinse containing 450 ppm F, while the group A will have everything the same except the mouthrinse that will contain no fluoride - a placebo mouthrinse.

Every 28 days buccal cells samples would be collected from each participant and a Buccal micronucleus cytome assay would be performed according to Nature protocols: Thomas et all.

The aim of this study would be to assess the possible cumulative effect of together use of fluoridated toothpastes and mouthrinses, since population worldwide uses them together without any exact studies about toxicity.

Condition or Disease Intervention/Treatment Phase
  • Other: Flouride in mouthrinses
  • Other: Placebo mouthrinse
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
In Vivo Assessment of Geno- and Cytotoxicity of Fluoridated Toothpastes and Mouthrinses on Human Buccal Epithelial Cells
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Feb 21, 2021
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo mouthrinse

Group that uses just toothpaste without fluoride for 28 days; toothpaste without flouride and mouthrinse without flouride for 28 days; toothpaste with 1050 ppm F and mouthrinse without flouride for 28 days; toothpaste with 1450 ppm F and mouthrinse without flouride for 28 days.

Other: Placebo mouthrinse
Mouthrinses without flouride

Experimental: Fluoride in mouthrinses

Group that uses just toothpaste without fluoride for 28 days; toothpaste without flouride and mouthrinse with 450 ppm F for 28 days; toothpaste with 1050 ppm F and mouthrinse with 450 ppm F for 28 days; toothpaste with 1450 ppm F and mouthrinse with 450 ppm F for 28 days.

Other: Flouride in mouthrinses
Custom made toothpastes and mouthrinses that do or do not contain flouride as sodium fluoride in different concentrations.

Outcome Measures

Primary Outcome Measures

  1. Number of patients with treatment-related cytotoxic and genotoxic events in buccal cells assessed by buccal cytome micronucleus assay. [112 days (4 periods of 28 days)]

    Method used is Buccal Micronucleus Cytome (BMCyt) assay as minimally invasive method for studying DNA damage, chromosomal instability, cell death and the regenerative potential of human buccal mucosal tissue. This is one of the current established methods for buccal cell collection using a small-headed toothbrush, the generation of a single-cell suspension, slide preparation using cytocentrifugation, fixation and staining using Feulgen and Light Green for both bright field and fluorescence microscopic analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy subjects

  • a sufficient level of education to understand the procedures

  • patients not younger than 18 and not older than 65 years

  • non-smokers

  • patients without exposure to any x-ray examination in last 6 months

Exclusion Criteria:
  • subjects with use of any medications

  • subjects that use alcohol

  • subjects with oral lesions

  • subjects with history of chronic health conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Split School of medicine Split Croatia 21000

Sponsors and Collaborators

  • University of Split, School of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ema Puizina Mladinić, MD, Principal investigator, University of Split, School of Medicine
ClinicalTrials.gov Identifier:
NCT04801576
Other Study ID Numbers:
  • EPuizina
First Posted:
Mar 17, 2021
Last Update Posted:
Jan 28, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 28, 2022